Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for Spasticity in Progressive MS
NCT01538225Phase 3Completed
- Sponsor
- Almirall
- Start
- Apr 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in multiple sclerosis (MS), sponsored by Almirall. Started Apr 2012; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01538225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538225.